UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 24, 2005
BIOPHAN TECHNOLOGIES, INC.
--------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-26057 82-0507874
---------------------------- -------------------- ----------------------
(State or other jurisdiction (Commission file No) (I.R.S. Employer
of Incorporation) Identification Number)
150 Lucius Gordon Drive, Suite 215
West Henrietta, New York
(Address of principal executive offices)
14586
(Zip code)
(585) 214-2441
(Registrant's telephone number)
Item 7.01 Regulation FD Disclosure
On October 24, 2005, the Company hosted an investor conference call with our
Chief Executive Officer Michael Weiner and Vice President, Business Development
John Lanzafame to provide a progress report on the Company's business, product
development and commercialization of our intellectual property portfolio. See
attached Exhibit 99.1 for a complete transcript of the call.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
Number Exhibit
------ -------
99.1 Transcript of Conference Call
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIOPHAN TECHNOLOGIES, INC.
--------------------------
(Registrant)
Date 10/25/05 /s/ Michael L. Weiner
-------------------- --------------------------------
(Signature)
Michael L. Weiner
Chief Executive Officer